Analysis of renal mononuclear phagocytes in murine models of SLE

Methods in Molecular Biology

Volumn 900, Issue , 2012, Pages 207-232

  Bethunaickan, Ramalingam ^a   Sahu, Ranjit ^a   Davidson, Anne ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Cell activation; Dendritic cells; Lupus; Macrophages; Murine models; Nephritis

Indexed keywords

EID: 84868547030     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-720-4_10     Document Type: Article

References (68)

1. Davidson A, Aranow C (2006) Pathogenesis and treatment of systemic lupus erythematosus nephritis. Curr Opin Rheumatol 18:468-4755
2. Chan TM (2005) Preventing renal failure in patients with severe lupus nephritis. Kidney Int Suppl 94:S116-S1199
3. Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D (2004) Sequential therapies for proliferative lupus nephritis. N Engl J Med 350:971-9800
4. Contreras G, Tozman E, Nahar N, Metz D (2005) Maintenance therapies for proliferative lupus nephritis: Mycophenolate mofetil, azathioprine and intravenous cyclophosphamide. Lupus 14(Suppl 1):s33-s388
5. Costenbader KH, Solomon DH, Winkelmayer W, Brookhart MA (2008) Incidence of end-stage renal disease due to lupus nephritis in the U.S., 1995-2004. Arthrit Rheum Abstract 19277
6. Schwartz MM (2007) The pathology of lupus nephritis. Semin Nephrol 27:22-344
7. Hill GS, Delahousse M, Nochy D, Mandet C, Bariety J (2001) Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 60: 1893-19033
8. Hill GS, Delahousse M, Nochy D, Remy P, Mignon F, Mery JP, Bariety J (2001) Predictive power of the second renal biopsy in lupus nephritis: Signi fi cance of macrophages. Kidney Int 59:304-3166
9. Li QZ, Xie C, Wu T, Mackay M, Aranow C, Putterman C, Mohan C (2005) Identi fi cation of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 115:3428-34399
10. Bagavant H, Fu SM (2005) New insights from murine lupus: Disassociation of autoimmunity and end organ damage and the role of T cells. Curr Opin Rheumatol 17:523-5288
11. Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ (2005) Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 202:321-3311
12. Turnberg D, Cook HT (2005) Complement and glomerulonephritis: New insights. Curr Opin Nephrol Hypertens 14:223-2288
13. Clynes R, Dumitru C, Ravetch JV (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052-10544
14. Anders HJ, Schlondorff D (2007) Toll-like receptors: Emerging concepts in kidney disease. Curr Opin Nephrol Hypertens 16:177-1833
15. Sesin CA, Yin X, Esmon CT, Buyon JP, Clancy RM (2005) Shedding of endothelial protein C receptor contributes to vasculopathy and renal injury in lupus: In vivo and in vitro evidence. Kidney Int 68:110-1200
16. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189:1639-16488
17. Lewis EJ, Schwartz MM (2005) Pathology of lupus nephritis. Lupus 14:31-388
18. Anders HJ, Ninichuk V, Schlondorff D (2006) Progression of kidney disease: Blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int 69:29-322
19. Holdsworth SR, Tipping PG (2007) Leukocytes in glomerular injury. Semin Immunopathol 29:355-3744
20. Foster MH (2007) T cells and B cells in lupus nephritis. Semin Nephrol 27:47-588
21. Schiffer L, Sinha J, Wang X, Huang W, von Gersdorff G, Schiffer M, Madaio MP, Davidson A (2003) Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol 171:489-4977
22. Daikh DI, Wofsy D (2001) Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J Immunol 166:2913-29166
23. Timoshanko JR, Sedgwick JD, Holdsworth SR, Tipping PG (2003) Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol 14: 1785-17933
24. Wang Y, Wang Y, Cai Q, Zheng G, Lee VW, Zheng D, Li X, Tan TK, Harris DC (2008) By homing to the kidney, activated macrophages potently exacerbate renal injury. Am J Pathol 172:1491-14999
25. Ferenbach D, Hughes J (2008) Macrophages and dendritic cells: What is the difference? Kidney Int 74:5-77
26. Kurts C, Heymann F, Lukacs-Kornek V, Boor P, Floege J (2007) Role of T cells and dendritic cells in glomerular immunopathology. Semin Immunopathol 29:317-3355
27. Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73:209-2122
28. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-6866
29. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-9699
30. Hume DA (2008) Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol 1:432-4411
31. Tacke F, Randolph GJ (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211:609-6188
32. Li L, Huang L, Sung SS, Vergis AL, Rosin DL, Rose CE Jr, Lobo PI, Okusa MD (2008) The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage traf fi cking in kidney ischemia-reperfusion injury. Kidney Int 74:1526-15377
33. Swaminathan S, Grif fi n MD (2008) First responders: Understanding monocyte-lineage traf fi c in the acutely injured kidney. Kidney Int 74:1509-15111
34. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317:666-6700
35. Geissmann F, Auffray C, Palframan R, Wirrig C, Ciocca A, Campisi L, Narni-Mancinelli E, Lauvau G (2008) Blood monocytes: Distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 86:398-4088
36. Skold M, Behar SM (2008) Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J Immunol 181: 6349-63600
37. Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453-4611
38. Wu L, Liu YJ (2007) Development of dendritic-cell lineages. Immunity 26:741-7500
39. Liu K, Waskow C, Liu X, Yao K, Hoh J, Nussenzweig M (2007) Origin of dendritic cells in peripheral lymphoid organs of mice. Nat Immunol 8:578-5833
40. Auffray C, Emre Y, Geissmann F (2008) Homeostasis of dendritic cell pool in lymphoid organs. Nat Immunol 9:584-5866
41. Kamath AT, Henri S, Battye F, Tough DF, Shortman K (2002) Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100:1734-17411
42. Kruger T, Benke D, Eitner F, Lang A, Wirtz M, Hamilton-Williams EE, Engel D, Giese B, Muller-Newen G, Floege J, Kurts C (2004) Identi fi cation and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol 15:613-6211
43. Soos TJ, Sims TN, Barisoni L, Lin K, Littman DR, Dustin ML, Nelson PJ (2006) CX3CR1+interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 70:591-5966
44. Segerer S, Heller F, Lindenmeyer MT, Schmid H, Cohen CD, Draganovici D, Mandelbaum J, Nelson PJ, Grone HJ, Grone EF, Figel AM, Nossner E, Schlondorff D (2008) Compartment speci fi c expression of dendritic cell markers in human glomerulonephritis. Kidney Int 74: 37-466
45. Kurts C (2006) Dendritic cells: Not just another cell type in the kidney, but a complex immune sentinel network. Kidney Int 70:412-4144
46. Bethunaickan R, Berthier CC, Ramanujam M, Sahu R, Zhang W, Sun Y, Bottinger EP, Ivashkiv L, Kretzler M, Davidson A (2011) A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis. J Immunol: 186:4994-50033
47. Ramanujam M, Davidson A (2008) Targeting of the immune system in systemic lupus erythematosus. Expert Rev Mol Med 10:e22
48. Singh RR, Saxena V, Zang S, Li L, Finkelman FD, Witte DP, Jacob CO (2003) Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 170:4818-48255
49. Santiago ML, Fossati L, Jacquet C, Muller W, Izui S, Reininger L (1997) Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 185:65-700
50. Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T (2003) Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Arthritis Rheum 48:486-4944
51. Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV (2006) TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 203:553-5611
52. Wu X, Peng SL (2006) Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 54:336-3422
53. Fu Y, Du Y, Mohan C (2007) Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis. Clin Immunol 124: 109-1188
54. Perry D, Sang A, Yin Y, Zheng YY, Morel L (2011) Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011:2716944
55. Ramanujam M, Wang X, Huang W, Liu Z, Schiffer L, Tao H, Frank D, Rice J, Diamond B, Yu KO, Porcelli S, Davidson A (2006) Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest 116:724-7344
56. Rudofsky UH, Lawrence DA (1999) New Zealand mixed mice: A genetic systemic lupus erythematosus model for assessing environmental effects. Environ Health Perspect 107: 713-7211
57. Ramanujam M, Davidson A (2008) BAFF blockade for systemic lupus erythematosus - will the promise be ful fi lled? Immunol Rev 223:156-1744
58. Pisitkun P, Deane JA, Di fi lippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S (2006) Autoreactive B cell responses to RNArelated antigens due to TLR7 gene duplication. Science 312:1669-16722
59. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J, Liang C, Bartov G, McDaniel LD, Zhou XJ, Schultz RA, Wakeland EK (2006) A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 103:9970-99755
60. Haywood ME, Rogers NJ, Rose SJ, Boyle J, McDermott A, Rankin JM, Thiruudaian V, Lewis MR, Fossati-Jimack L, Izui S, Walport MJ, Morley BJ (2004) Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease. J Immunol 173:4277-42855
61. Akkerman A, Huang W, Wang X, Ramanujam M, Schiffer L, Madaio M, Factor SM, Davidson A (2004) CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice. Autoimmunity 37:445-4511
62. Kahn P, Ramanujam M, Bethunaickan R, Huang W, Tao H, Madaio MP, Factor SM, Davidson A (2008) Prevention of murine antiphospholipid syndrome by BAFF blockade. Arthritis Rheum 58:2824-28344
63. Hang LM, Izui S, Dixon FJ (1981) (NZW BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med 154:216-2211
64. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-3177
65. Andrews BS, Eisenberg RA, Theo fi lopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ (1978) Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148:1198-12155
66. Menke J, Rabacal WA, Byrne KT, Iwata Y, Schwartz MM, Stanley ER, Schwarting A, Kelley VR (2009) Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis. J Am Soc Nephrol 20:2581-25922
67. Hoi AY, Hickey MJ, Hall P, Yamana J, O'Sullivan KM, Santos LL, James WG, Kitching AR, Morand EF (2006) Macrophage migration inhibitory factor de fi ciency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice. J Immunol 177:5687-56966
68. Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, Madaio MP, Bottinger EP, Davidson A (2008) Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 180:1938-19477